Sano, M., Takei, M., Shiraishi, Y., & Suzuki, Y. (2016). Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys. J Clin Med Res.
استشهاد بنمط شيكاغوSano, Motoaki, Makoto Takei, Yasuyuki Shiraishi, و Yoshihiko Suzuki. "Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys." J Clin Med Res 2016.
MLA استشهادSano, Motoaki, Makoto Takei, Yasuyuki Shiraishi, و Yoshihiko Suzuki. "Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys." J Clin Med Res 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.